Citations

Clear

83 citation(s) found for "Shen, Win".

Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling
Wang, Xiao-Li, Sun, Xiaojing , Chai, Qiang , Thompson, Benjamin , Shen, Win-Kuang, Lü, Tong , Lee, Hon-Chi, Li, Jingchao, Li, Yong , Wang, Xiao-Li, Li, Jingchao , Lu, Tong

Mayo Clinic

Diabetes and Vascular Disease Research | April 21, 2017 | Volume: 14 | Issue: 4 | Pages: 353-362

10.1177/1479164117703903 | PMID 28429615 Get It

BK channels are major ionic determinants of vasodilation. BK channel function is impaired in diabetic vessels due to accelerated proteolysis of its beta-1 (BK-β1) subunits in response to increased oxidative stress. The nuclear factor E2-related factor-2 (Nrf2) signalling pathway has emerged as a master regulator of cellular redox status, and we hypothesized that it plays a central role in regulating BK channel function in diabetic vessels. We found that Nrf2 expression was markedly reduced in db/db diabetic mouse aortas, and this was associated with significant downregulation of BK-β1. In addition, the muscle ring finger protein 1 (MuRF1), a known E-3 ligase targeting BK-β1 ubiquitination and proteasomal degradation, was significantly augmented. These findings were reproduced by knockdown of Nrf2 by siRNA in cultured human coronary artery smooth muscle cells. In contrast, adenoviral transfer of Nrf2 gene in these cells downregulated MuRF1 and upregulated BK-β1 expression. Activation of Nrf2 by dimethyl fumarate preserved BK-β1 expression and protected BK channel and vascular function in db/db coronary arteries. These results indicate that expression of BK-β1 is closely regulated by Nrf2 and vascular BK channel function can be restored by Nrf2 activation. Nrf2 should be considered a novel therapeutic target in the treatment of diabetic vasculopathy.
Selective Modulation of the Cardiac Autonomic Nervous System
Mulpuru, Siva K. , Shen, Win-Kuang

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 15, 2017 | Volume: 10 | Issue: 2 | Pages: No page available

10.1161/circep.117.004994 | PMID 28202632 Get It

Incidence of Idiopathic Ventricular Arrhythmias
Sirichand, Surksha , Killu, Ammar M. , Padmanabhan, Deepak , Hodge, David O. , Chamberlain, Alanna M. , Brady, Peter A. , Packer, Douglas L. , Munger, Thomas M. , Shen, Win-Kuang, Cha, Yong‐Mei , Asirvatham, Samuel J. , Friedman, Paul A. , Mulpuru, Siva K. , Kapa, Suraj , Noseworthy, Peter A. , Gersh, Bernard J. , McLeod, Christopher J. , Asirvatham, Samuel J , Chamberlain, Alanna M

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 9, 2017 | Volume: 10 | Issue: 2 | Pages: No page available

10.1161/circep.116.004662 | PMID 28183845 Get It

Background— Ventricular tachycardia and premature ventricular complexes (PVCs) most frequently occur in the context of structural heart disease. However, the burden of idiopathic ventricular arrhythmias (IVA) in the general population is unknown. Methods and Results— We identified incident cases of IVA between 2005 and 2013 from Olmsted County, Minnesota, using the Rochester Epidemiology Project database. For PVC cohorts, we included those with frequent (defined as ≥100 PVC/24 hours) symptomatic PVCs. We defined IVA-associated cardiomyopathy as a drop in ejection fraction of ≥10% from baseline. Between 2005 and 2013, we identified 614 individuals with incident IVA (229 [37.3%] were male; average age was 52.1±17.2 years). Of these, 177 (28.8%) had idiopathic ventricular tachycardia, 408 (66.5%) had symptomatic PVCs, and 29 (4.7%) had IVA-associated cardiomyopathy. The age- and sex-adjusted incidence rates in 2005 to 2007, 2008 to 2010, and 2011 to 2013 were 44.9 per 100 000 (95% confidence interval [CI], 38.0–51.8), 47.6 per 100 000 (95% CI, 40.8–54.5), and 62.0 per 100 000 (95% CI, 54.4–69.6), respectively. In idiopathic ventricular tachycardia, there was an increase in incidence rate with ages ( P <0.001) but not between sexes ( P =0.12). The age-adjusted incidence of symptomatic PVC was higher in females than in males (46.2 per 100 000 [95% CI, 40.9–51.6] versus 20.5 per 100 000 [95% CI, 16.8–24.3]; P <0.001). The small number of individuals with IVA-associated cardiomyopathy precluded any formal testing. Conclusions— The incidence of IVA is increasing. Furthermore, overall incidence increases with age. Although the rate of idiopathic ventricular tachycardia is similar across sexes, women have a higher incidence of symptomatic PVC.
Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation
Wang, Ruxing , Lee, Hon‐Chi, Li, Jiaping , Hodge, David O. , Cha, Yong‐Mei , Friedman, Paul A. , Munger, Thomas M. , Pavri, Behzad B. , Shen, Win‐Kuang , Srivathsan, Komandoor

Mayo Clinic

Clinical Cardiology | October 17, 2016 | Volume: 40 | Issue: 1 | Pages: 18-25

10.1002/clc.22600 | PMID 27748530 Get It

BackgroundAlthough sudden death (SD) is a rare complication after atrioventricular junction (AVJ) ablation and permanent pacemaker implantation, the risk factors leading to this SD remain unknown. The purpose of this study was to investigate SD and its risk factors after ablate‐and‐pace strategy for rate control in atrial fibrillation (AF) patients during long‐term follow‐up.HypothesisMethodsFrom January 2005 to December 2009, we enrolled into this study 517 AF patients with AVJ ablation and right ventricular pacemaker implantation. Patients were divided into 2 groups, SD and non‐SD. Cox proportional hazards models were used to assess potential risk factors for overall mortality and SD.ResultsDuring a mean follow‐up of 25.8 ± 18.6 months (range, 3 days to 63.8 months), 53 patients died (15 with SD). Cox proportional hazards models showed that the presence of congestive heart failure, New York Heart Association functional class, chronic renal failure, and nonsustained ventricular tachycardia were risk factors that predicted overall mortality. For SD, the presence of dilated cardiomyopathy and mitral stenosis were associated risk factors. SD was exclusively seen in patients who had narrow QRS complex or right bundle branch block prior to AVJ ablation and pacemaker implantation; SD was not seen in any patient with preexisting complete left bundle branch block.ConclusionsDilated cardiomyopathy, mitral stenosis, and baseline QRS morphology should be examined as potential risk factors for SD after AVJ ablation and pacemaker implantation.
Knowledge Gaps in Cardiovascular Care of Older Adults: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: Executive Summary
Rich, Michael W. , Chyun, Deborah , Skolnick, Adam H. , Kitzman, Dalane W. , McClurken, James B., Shen, Win K., Tirschwell, David , Alexander, Karen P. , Forman, Daniel E. , Maurer, Matthew J. , Resnick, Barbara M.

Mayo Clinic

Journal of the American Geriatrics Society | September 27, 2016 | Volume: 64 | Issue: 11 | Pages: 2185-2192

10.1111/jgs.14576 | PMID 27673575 Get It

The incidence and prevalence of most cardiovascular disorders increase with age, and cardiovascular disease ( CVD ) is the leading cause of death and major disability in adults aged 75 and older. Despite the effect of CVD on quality of life, morbidity, and mortality in older adults, individuals aged 75 and older have been markedly underrepresented in most major cardiovascular trials, and virtually all trials have excluded older adults with complex comorbidities, significant physical or cognitive disabilities, frailty, or residence in nursing homes and assisted living facilities. As a result, current guidelines are unable to provide evidence‐based recommendations for diagnosis and treatment of older adults typical of those encountered in routine clinical practice. The objectives of this scientific statement are to summarize current guideline recommendations as they apply to older adults, identify critical gaps in knowledge that preclude informed evidence‐based decision‐making, and recommend future research to close existing knowledge gaps. To achieve these objectives, a detailed review was conducted of current American College of Cardiology/American Heart Association ( ACC / AHA ) and American Stroke Association ( ASA ) guidelines to identify content and recommendations that explicitly targeted older adults. A pervasive lack of evidence to guide clinical decision‐making in older adults with CVD was found, as well as a paucity of data on the effect of diagnostic and therapeutic interventions on outcomes that are particularly important to older adults, such as quality of life, physical function, and maintenance of independence. Accordingly, there is a critical need for a multitude of large population‐based studies and clinical trials that include a broad spectrum of older adults representative of those seen in clinical practice and that incorporate relevant outcomes important to older adults in the study design. The results of these studies will provide the foundation for future evidence‐based guidelines applicable to older adults and enhance person‐centered care of older individuals with CVD in the United States and around the world.
Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability
Cha, Yong‐Mei , Dzeja, Petras P. , Shen, Win K., Hart, Chari Y. T., Redfield, Margaret M. , Jahangir, Arshad , Terzic, André

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | March 3, 2015 | Volume: 284 | Issue: 4 | Pages: H1313-H1320

10.1152/ajpheart.00337.2002 | PMID 12626329 Get It

The failing ventricular myocardium is characterized by reduction of high-energy phosphates and reduced activity of the phosphotransfer enzymes creatine kinase (CK) and adenylate kinase (AK), which are responsible for transfer of high-energy phosphoryls from sites of production to sites of utilization, thereby compromising excitation-contraction coupling. In humans with chronic atrial fibrillation (AF) unassociated with congestive heart failure (CHF), impairment of atrial myofibrillar energetics linked to oxidative modification of myofibrillar CK has been observed. However, the bioenergetic status of the failing atrial myocardium and its potential contribution to atrial electrical instability in CHF have not been determined. Dogs with ( n = 6) and without ( n = 6) rapid pacing-induced CHF underwent echocardiography (conscious) and electrophysiological (under anesthesia) studies. CHF dogs had more pronounced mitral regurgitation, higher atrial pressure, larger atrial area, and increased atrial fibrosis. An enhanced propensity to sustain AF was observed in CHF, despite significant increases in atrial effective refractory period and wavelength. Profound deficits in atrial bioenergetics were present with reduced activities of the phosphotransfer enzymes CK and AK, depletion of high-energy phosphates (ATP and creatine phosphate), and reduction of cellular energetic potential (ATP-to-ADP and creatine phosphate-to-Cr ratios). AF duration correlated with left atrial area ( r = 0.73, P = 0.01) and inversely with atrial ATP concentration ( r = −0.75, P = 0.005), CK activity ( r = −0.57, P = 0.054), and AK activity ( r = −0.64, P = 0.02). Atrial levels of malondialdehyde, a marker of oxidative stress, were significantly increased in CHF. Myocardial bioenergetic deficits are a conserved feature of dysfunctional atrial and ventricular myocardium in CHF and may constitute a component of the substrate for AF in CHF.
Atrial Fibrillation in the Elderly: A Review
Hakim, Fayaz A., Shen, Win-Kuang

Mayo Clinic

Future Cardiology | December 12, 2014 | Volume: 10 | Issue: 6 | Pages: 745-758

10.2217/fca.14.32 | PMID 25495816 Get It

HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Calkins, Hugh , Boehmer, John , Buxton, Alfred E. , Chung, Mina K. , Gold, Michael R. , Hohnloser, Stefan H. , Indik, Julia H. , Mehra, Mandeep R. , Menon, Venu , Page, Richard L. , Shen, Win‐Kuang , Slotwiner, David J. , Stevenson, Lynne W. , Varosy, Paul D. , Welikovitch, Lisa, Kusumoto, Fred M, Indik, Julia, Stevenson, Lynne Warner, Kusumoto, Fred , Lee, Richard Theodore , Shen, Win-Kuang, Mehra, Mandeep R

Mayo Clinic

Circulation | May 9, 2014 | Volume: 130 | Issue: 1 | Pages: 94-125

10.1161/cir.0000000000000056 | PMID 24815500 Get It

Magnetic Resonance Imaging in Patients with Recently Implanted Pacemakers
Friedman, Hannah, Acker, Nancy, Dalzell, Connie, Shen, Win K., Asirvatham, Samuel J. , Cha, Yong‐Mei , Hodge, David O. , Felmlee, Joel P. , Watson, Robert E. , Friedman, Paul A. , Friedman, Hannah L, Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | July 4, 2013 | Volume: 36 | Issue: 9 | Pages: 1090-1095

10.1111/pace.12213 | PMID 23826621 Get It

BackgroundRecent studies have shown that magnetic resonance imaging (MRI) of patients with pacemakers can be safely performed under careful monitoring, but they excluded patients with recently implanted devices. Patients with recent implants may be at a greater risk for complications during MRI imaging due to lack of lead and wound maturity.MethodsWe implemented a clinical protocol for MRI imaging of patients with implanted cardiac devices, and prospectively collected data. For this study, we retrospectively analyzed two groups of patients: those with recently implanted (≤42 days) and nonrecently implanted (>42 days) leads at the time of MRI scanning. All devices were interrogated before and after scanning, and were reprogrammed during the scan as per protocol.ResultsOf the 219 scans (in 171 patients), eight included patients with recently implanted (range: 7–36 days) and 211 with only nonrecently implanted pacemaker leads. During the scan, there were no complications in the early or late group. In one patient imaged 79 days postimplant, frequent premature ventricular complexes were noted during the scan, requiring no action. No patient reported pain during or immediately after the procedure. No clinically significant changes in function were seen at subsequent follow up (average 104 days post‐MRI). Compared to patients with nonrecently implanted leads, there was no difference in any parameter between the two groups.ConclusionsWith a strong clinical indication and with careful monitoring, MRI imaging is feasible in patients with recently implanted pacemakers, although experience is limited.
The Natural History of Lone Atrial Flutter
Halligan, Sean C., Brown, Robert D., Rosales, A. Gabriela , Munger, Thomas M. , Shen, Win-Kuang, Hammill, Stephen C., Friedman, Paul A. , Gersh, Bernard J.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 140 | Issue: 4 | Pages: 265-268

10.7326/0003-4819-140-4-200402170-00008 | PMID 14970149 Get It